US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Celon Pharma SA (0RKX) 銘柄情報

Celon Pharma SA (0RKX)

29.00

0.00

(0.00%)

終了 7月12日 12:30AM

Celon Pharma SA (0RKX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

29.00

( - )

買値

29.00

売値

29.00

出来高

0.00

平均取引量 (3 か月)

PLN 8,773

財務取引量

-

0.00 日の範囲 0.00

29.00 52 週間の範囲 29.00

時価総額

企業価値

1.11B

前日終値

29.00

始値

-

時刻

最終取引時間

VWAP

-

歳入

256.54M

純利益

108.32M

発行済株式数

53,856,500

浮動株比率 (%)

44.23%

機関投資家保有比率 (%)

17.98%

配当利回り

PER

9.74

株価売上高倍率 (PSR)

4.15

1 株当たり利益 (EPS)

2.03

ベータ

0.67

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is base... Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp. z o.o. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

www.celonpharma.com

本社

Lomianki, Poland

設立

2026

Celon Pharma SA is listed in the Health Care sector of the ロンドン証券取引所 with ticker 0RKX. The last closing price for Celon Pharma was PLN29. Over the last year, Celon Pharma shares have traded in a share price range of PLN 29.00 to PLN 29.00.

Celon Pharma currently has 53,856,500 shares in issue. The market capitalisation of Celon Pharma is PLN1.56 billion. Celon Pharma has a price to earnings ratio (PE ratio) of 9.74.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	29	29	29	0	0	DE
52	0	0	29	29	29	0	0	DE
156	0	0	29	29	29	2056	29	DE
260	0	0	29	29	29	1182	29	DE

0RKX - Frequently Asked Questions (FAQ)

What is the current Celon Pharma SA share price?

The current share price of Celon Pharma SA is PLN 29.00

How many Celon Pharma SA shares are in issue?

Celon Pharma SA has 53,856,500 shares in issue

What is the market cap of Celon Pharma SA?

The market capitalisation of Celon Pharma SA is PLN 1.56B

What is the 1 year trading range for Celon Pharma SA share price?

Celon Pharma SA has traded in the range of PLN 29.00 to PLN 29.00 during the past year

What is the PE ratio of Celon Pharma SA?

The price to earnings ratio of Celon Pharma SA is 9.74

What is the cash to sales ratio of Celon Pharma SA?

The cash to sales ratio of Celon Pharma SA is 4.15

What is the registered address of Celon Pharma SA?

The registered address for Celon Pharma SA is Ogrodowa 2A, Lomianki, 05-092

What is the Celon Pharma SA website address?

The website address for Celon Pharma SA is www.celonpharma.com

PickStocks

PickStocks 2分前

Quote: “ Liquidating Trust Interests (which hold the residual value of tax attributes and litigation settlements) move down the waterfall to equity holders.” all or if any money was sent to the WMILT for distribution if there was any. .. which was donated with what was left……

Eli's Gone

Eli's Gone 3分前

J0L

https://x.com/joltrades/status/2076077951469388044?s=46

ListenToTheTrees

ListenToTheTrees 8分前

Your conclusion still rests on a false premise: that if a business initiative doesn’t ultimately succeed, it must have been intended to fail.

That’s not how business, or evidence, works.

Public company history is full of products that never gained traction, acquisitions

jimr1717

jimr1717 10分前

This absolute Filth hasn’t been Revoked yet? Amazing

Naught

Naught 10分前

Ron
What was your estimate of the pref payout from.the PAC distribution? .6xFV?

beacham

beacham 12分前

A money minute ...

If there are 100,000 in stock doesn't that mean that Electrome purchased 100,000 units from BIEL ?? Assuming a $10 profit (realistic?) on each unit, then we are looking at $1 million in revenue for BIEL for 2026 and we still have over 5 months left.

mining hound

mining hound 14分前

hi everyone,USA in its 250th celebration year from the Decl. of Independence, no news to share, but hope everyone is well

Investor2014

Investor2014 14分前

Useless nonsense!

Investor2014

Investor2014 14分前

Useless nonsense!

BottomBounce

BottomBounce 27分前

🤖 Why Different AIs Give You Different Answers The Big Reveal: It’s Not About Lying, It’s About AI has existed for more than 75 years — it’s not some brand-new invention. What’s changed is how it’s packaged and presented. Different groups frame it to fit the narrative they want you to believ

Schekin

Schekin 27分前

I think we’re done hearing of more “developments”.. If we hear anything more it’ll be more definitive. Launch or not…

Real McCoy

Real McCoy 31分前

Nice roast.

Don’t let these liars off the hook.

boston127

boston127 33分前

I hope you are correct. EOM

TenKay

TenKay 34分前

“That is a false choice.“

LOL…no it isn’t.

Literally everything failed.

Either he was incompetent and could not execute

Or…

They were never done to be successful or with any expectation of success. They served a purpose in p

100lbStriper

100lbStriper 37分前

lol!!! i cant help it, its a natural response for me. its like sittin down playin music with some one. you call, i respond. in fact its actually a musicians term, call and response!!!

ListenToTheTrees

ListenToTheTrees 44分前

That is a false choice.

Business outcomes are not limited to only two explanations: incompetence or fraud. Deals can fail because of financing constraints, market conditions, regulatory issues, integration problems, changing strategy, partner failures, execution mistakes, or assumptio

waterchaser

waterchaser 45分前

Yet HIRU is still basically WORTHLESS.
Some things never change on the scam OTC.

Newtogame

Newtogame 47分前

Tazzie 5-22-12-7 Moose 12-9-7-2 Chance 12-5-2-48 New 12-2-7-9
GLTA

layton

layton 47分前

I’ve seen it all and heard it all on these Pink Sheets…..

lakers17

lakers17 49分前

Same lame divy ploy and lame pump. How about an actual PR from the company on this? And most importantly if there is actually a divy will it be restricted as most likely or if not restricted free trading shares? What the whale guy posted said restricted. Company needs to actually PR with the det

TenKay

TenKay 49分前

“The reverse split wasn’t “hidden.” Reverse splits require board approval, regulatory filings, and notice before becoming effective.“

You seem to forget they were not an SEC filer back then. There was no notice or filings. Only when it hit the dailylist with FINRA was it revealed an

Up Global Sourcing

St George Mining

Nts 6.500% Due 5/16/2044

NextGen Food Robotics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。